0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global On-body Injectors Market Research Report 2026
Published Date: 2026-04-18
|
Report Code: QYRE-Auto-31F6775
Home | Market Reports
Global On body Injectors Market Insights and Forecast to 2028
BUY CHAPTERS

Global On-body Injectors Market Research Report 2026

Code: QYRE-Auto-31F6775
Report
2026-04-18
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

On-body Injectors Market Size

The global On-body Injectors market was valued at US$ 207 million in 2025 and is anticipated to reach US$ 595 million by 2032, at a CAGR of 16.5% from 2026 to 2032.

On-body Injectors Market

On-body Injectors Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on On-body Injectors competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
On-body injectors, also known as on-body delivery systems (OBDS), are medical devices designed to deliver a controlled dose of medication or therapeutic substances subcutaneously (under the skin) over a specified period. These devices are typically worn on the body and are used to administer various treatments, including medications, hormones, and biologics. On-body injectors offer several advantages, including increased patient convenience, improved medication adherence, and the ability to deliver complex therapies. The scope of this report is non-insulin On-body injectors.
In 2024, the global sales ofnon-insulin on-body injectorsreached approximately5 million units, with an average market price of$35 per unit.
North America is currently the largest market for on-body injectors, driven by high healthcare spending, early adoption of advanced drug delivery technologies, and a strong presence of key players such as Amgen (with its Neulasta® Onpro® kit). The United States leads in the development and approval of wearable drug delivery systems, especially for chronic conditions like cancer and autoimmune diseases. Growing demand for home-based treatment and reduced hospital visits post-COVID-19 has further accelerated market expansion.
Europe is a strong and steadily growing market for on-body injectors, supported by rising prevalence of chronic diseases, aging populations, and robust healthcare infrastructure. Countries such as Germany, the UK, and France are key adopters, with regulatory support for patient-centric drug delivery systems. The focus on reducing hospital burden and improving patient compliance is encouraging healthcare providers to adopt wearable injectors, particularly for biologics and long-term therapies.
Asia-Pacific is the fastest-growing region for on-body injectors, driven by increasing healthcare awareness, expanding middle-class populations, and rising chronic disease incidence. Countries like China, Japan, and South Korea are investing heavily in digital health and self-administered therapies.
This report delivers a comprehensive overview of the global On-body Injectors market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding On-body Injectors. The On-body Injectors market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global On-body Injectors market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist On-body Injectors manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of On-body Injectors Market Report

Report Metric Details
Report Name On-body Injectors Market
Accounted market size in 2025 US$ 207 million
Forecasted market size in 2032 US$ 595 million
CAGR 16.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Electronic Injectors
  • Mechanical Injectors
by Application
  • Immuno-oncology
  • Cardiovascular Diseases
  • Neurological Diseases
  • Others
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, Sonceboz, Lohmann Therapie-Systeme, Elcam Drug Delivery Devices (E3D), MicroMED, Altek Medical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for On-body Injectors manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines On-body Injectors sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is On-body Injectors Market growing?

Ans: The On-body Injectors Market witnessing a CAGR of 16.5% during the forecast period 2026-2032.

What is the On-body Injectors Market size in 2032?

Ans: The On-body Injectors Market size in 2032 will be US$ 595 million.

Who are the main players in the On-body Injectors Market report?

Ans: The main players in the On-body Injectors Market are West Pharmaceutical Services, Insulet, Gerresheimer, United Therapeutics, CC Bio, BD, Ypsomed, Enable Injections, Nemera, Stevanato Group, Sonceboz, Lohmann Therapie-Systeme, Elcam Drug Delivery Devices (E3D), MicroMED, Altek Medical

What are the Application segmentation covered in the On-body Injectors Market report?

Ans: The Applications covered in the On-body Injectors Market report are Immuno-oncology, Cardiovascular Diseases, Neurological Diseases, Others

What are the Type segmentation covered in the On-body Injectors Market report?

Ans: The Types covered in the On-body Injectors Market report are Electronic Injectors, Mechanical Injectors

1 On-body Injectors Market Overview
1.1 Product Definition
1.2 On-body Injectors by Type
1.2.1 Global On-body Injectors Market Value by Type: 2025 vs 2032
1.2.2 Electronic Injectors
1.2.3 Mechanical Injectors
1.3 On-body Injectors by Application
1.3.1 Global On-body Injectors Market Value by Application: 2025 vs 2032
1.3.2 Immuno-oncology
1.3.3 Cardiovascular Diseases
1.3.4 Neurological Diseases
1.3.5 Others
1.4 Global On-body Injectors Market Size Estimates and Forecasts
1.4.1 Global On-body Injectors Revenue 2021–2032
1.4.2 Global On-body Injectors Sales 2021–2032
1.4.3 Global On-body Injectors Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 On-body Injectors Market Competition by Manufacturers
2.1 Global On-body Injectors Sales Market Share by Manufacturers (2021–2026)
2.2 Global On-body Injectors Revenue Market Share by Manufacturers (2021–2026)
2.3 Global On-body Injectors Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of On-body Injectors, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of On-body Injectors, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of On-body Injectors, Product Types and Applications
2.7 Global Key Manufacturers of On-body Injectors, Date of Entry into the Industry
2.8 Global On-body Injectors Market Competitive Situation and Trends
2.8.1 Global On-body Injectors Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global On-body Injectors Players Market Share by Revenue
2.8.3 Global On-body Injectors Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global On-body Injectors Market Scenario by Region
3.1 Global On-body Injectors Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global On-body Injectors Sales by Region: 2021–2032
3.2.1 Global On-body Injectors Sales by Region: 2021–2026
3.2.2 Global On-body Injectors Sales by Region: 2027–2032
3.3 Global On-body Injectors Revenue by Region: 2021–2032
3.3.1 Global On-body Injectors Revenue by Region: 2021–2026
3.3.2 Global On-body Injectors Revenue by Region: 2027–2032
3.4 North America On-body Injectors Market Facts & Figures by Country
3.4.1 North America On-body Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America On-body Injectors Sales by Country (2021–2032)
3.4.3 North America On-body Injectors Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe On-body Injectors Market Facts & Figures by Country
3.5.1 Europe On-body Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe On-body Injectors Sales by Country (2021–2032)
3.5.3 Europe On-body Injectors Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific On-body Injectors Market Facts & Figures by Region
3.6.1 Asia Pacific On-body Injectors Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific On-body Injectors Sales by Region (2021–2032)
3.6.3 Asia Pacific On-body Injectors Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America On-body Injectors Market Facts & Figures by Country
3.7.1 Latin America On-body Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America On-body Injectors Sales by Country (2021–2032)
3.7.3 Latin America On-body Injectors Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa On-body Injectors Market Facts & Figures by Country
3.8.1 Middle East and Africa On-body Injectors Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa On-body Injectors Sales by Country (2021–2032)
3.8.3 Middle East and Africa On-body Injectors Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global On-body Injectors Sales by Type (2021–2032)
4.1.1 Global On-body Injectors Sales by Type (2021–2026)
4.1.2 Global On-body Injectors Sales by Type (2027–2032)
4.1.3 Global On-body Injectors Sales Market Share by Type (2021–2032)
4.2 Global On-body Injectors Revenue by Type (2021–2032)
4.2.1 Global On-body Injectors Revenue by Type (2021–2026)
4.2.2 Global On-body Injectors Revenue by Type (2027–2032)
4.2.3 Global On-body Injectors Revenue Market Share by Type (2021–2032)
4.3 Global On-body Injectors Price by Type (2021–2032)
5 Segment by Application
5.1 Global On-body Injectors Sales by Application (2021–2032)
5.1.1 Global On-body Injectors Sales by Application (2021–2026)
5.1.2 Global On-body Injectors Sales by Application (2027–2032)
5.1.3 Global On-body Injectors Sales Market Share by Application (2021–2032)
5.2 Global On-body Injectors Revenue by Application (2021–2032)
5.2.1 Global On-body Injectors Revenue by Application (2021–2026)
5.2.2 Global On-body Injectors Revenue by Application (2027–2032)
5.2.3 Global On-body Injectors Revenue Market Share by Application (2021–2032)
5.3 Global On-body Injectors Price by Application (2021–2032)
6 Key Companies Profiled
6.1 West Pharmaceutical Services
6.1.1 West Pharmaceutical Services Company Information
6.1.2 West Pharmaceutical Services Description and Business Overview
6.1.3 West Pharmaceutical Services On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 West Pharmaceutical Services On-body Injectors Product Portfolio
6.1.5 West Pharmaceutical Services Recent Developments/Updates
6.2 Insulet
6.2.1 Insulet Company Information
6.2.2 Insulet Description and Business Overview
6.2.3 Insulet On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Insulet On-body Injectors Product Portfolio
6.2.5 Insulet Recent Developments/Updates
6.3 Gerresheimer
6.3.1 Gerresheimer Company Information
6.3.2 Gerresheimer Description and Business Overview
6.3.3 Gerresheimer On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Gerresheimer On-body Injectors Product Portfolio
6.3.5 Gerresheimer Recent Developments/Updates
6.4 United Therapeutics
6.4.1 United Therapeutics Company Information
6.4.2 United Therapeutics Description and Business Overview
6.4.3 United Therapeutics On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 United Therapeutics On-body Injectors Product Portfolio
6.4.5 United Therapeutics Recent Developments/Updates
6.5 CC Bio
6.5.1 CC Bio Company Information
6.5.2 CC Bio Description and Business Overview
6.5.3 CC Bio On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 CC Bio On-body Injectors Product Portfolio
6.5.5 CC Bio Recent Developments/Updates
6.6 BD
6.6.1 BD Company Information
6.6.2 BD Description and Business Overview
6.6.3 BD On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 BD On-body Injectors Product Portfolio
6.6.5 BD Recent Developments/Updates
6.7 Ypsomed
6.7.1 Ypsomed Company Information
6.7.2 Ypsomed Description and Business Overview
6.7.3 Ypsomed On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Ypsomed On-body Injectors Product Portfolio
6.7.5 Ypsomed Recent Developments/Updates
6.8 Enable Injections
6.8.1 Enable Injections Company Information
6.8.2 Enable Injections Description and Business Overview
6.8.3 Enable Injections On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Enable Injections On-body Injectors Product Portfolio
6.8.5 Enable Injections Recent Developments/Updates
6.9 Nemera
6.9.1 Nemera Company Information
6.9.2 Nemera Description and Business Overview
6.9.3 Nemera On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Nemera On-body Injectors Product Portfolio
6.9.5 Nemera Recent Developments/Updates
6.10 Stevanato Group
6.10.1 Stevanato Group Company Information
6.10.2 Stevanato Group Description and Business Overview
6.10.3 Stevanato Group On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Stevanato Group On-body Injectors Product Portfolio
6.10.5 Stevanato Group Recent Developments/Updates
6.11 Sonceboz
6.11.1 Sonceboz Company Information
6.11.2 Sonceboz Description and Business Overview
6.11.3 Sonceboz On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Sonceboz On-body Injectors Product Portfolio
6.11.5 Sonceboz Recent Developments/Updates
6.12 Lohmann Therapie-Systeme
6.12.1 Lohmann Therapie-Systeme Company Information
6.12.2 Lohmann Therapie-Systeme Description and Business Overview
6.12.3 Lohmann Therapie-Systeme On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Lohmann Therapie-Systeme On-body Injectors Product Portfolio
6.12.5 Lohmann Therapie-Systeme Recent Developments/Updates
6.13 Elcam Drug Delivery Devices (E3D)
6.13.1 Elcam Drug Delivery Devices (E3D) Company Information
6.13.2 Elcam Drug Delivery Devices (E3D) Description and Business Overview
6.13.3 Elcam Drug Delivery Devices (E3D) On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Elcam Drug Delivery Devices (E3D) On-body Injectors Product Portfolio
6.13.5 Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
6.14 MicroMED
6.14.1 MicroMED Company Information
6.14.2 MicroMED Description and Business Overview
6.14.3 MicroMED On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.14.4 MicroMED On-body Injectors Product Portfolio
6.14.5 MicroMED Recent Developments/Updates
6.15 Altek Medical
6.15.1 Altek Medical Company Information
6.15.2 Altek Medical Description and Business Overview
6.15.3 Altek Medical On-body Injectors Sales, Revenue, and Gross Margin (2021–2026)
6.15.4 Altek Medical On-body Injectors Product Portfolio
6.15.5 Altek Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 On-body Injectors Industry Chain Analysis
7.2 On-body Injectors Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 On-body Injectors Production Mode & Process Analysis
7.4 On-body Injectors Sales and Marketing
7.4.1 On-body Injectors Sales Channels
7.4.2 On-body Injectors Distributors
7.5 On-body Injectors Customer Analysis
8 On-body Injectors Market Dynamics
8.1 On-body Injectors Industry Trends
8.2 On-body Injectors Market Drivers
8.3 On-body Injectors Market Challenges
8.4 On-body Injectors Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global On-body Injectors Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global On-body Injectors Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global On-body Injectors Market Competitive Situation by Manufacturers in 2025
 Table 4. Global On-body Injectors Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global On-body Injectors Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global On-body Injectors Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global On-body Injectors Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market On-body Injectors Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of On-body Injectors, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of On-body Injectors, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of On-body Injectors, Product Types and Applications
 Table 12. Global Key Manufacturers of On-body Injectors, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global On-body Injectors Companies by Tier (Tier 1, Tier 2, Tier 3), based on On-body Injectors Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global On-body Injectors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global On-body Injectors Sales by Region (K Units), 2021–2026
 Table 18. Global On-body Injectors Sales Market Share by Region (2021–2026)
 Table 19. Global On-body Injectors Sales by Region (K Units), 2027–2032
 Table 20. Global On-body Injectors Sales Market Share by Region (2027–2032)
 Table 21. Global On-body Injectors Revenue by Region (US$ Million), 2021–2026
 Table 22. Global On-body Injectors Revenue Market Share by Region (2021–2026)
 Table 23. Global On-body Injectors Revenue by Region (US$ Million), 2027–2032
 Table 24. Global On-body Injectors Revenue Market Share by Region (2027–2032)
 Table 25. North America On-body Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America On-body Injectors Sales by Country (K Units), 2021–2026
 Table 27. North America On-body Injectors Sales by Country (K Units), 2027–2032
 Table 28. North America On-body Injectors Revenue by Country (US$ Million), 2021–2026
 Table 29. North America On-body Injectors Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe On-body Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe On-body Injectors Sales by Country (K Units), 2021–2026
 Table 32. Europe On-body Injectors Sales by Country (K Units), 2027–2032
 Table 33. Europe On-body Injectors Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe On-body Injectors Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific On-body Injectors Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific On-body Injectors Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific On-body Injectors Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific On-body Injectors Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific On-body Injectors Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America On-body Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America On-body Injectors Sales by Country (K Units), 2021–2026
 Table 42. Latin America On-body Injectors Sales by Country (K Units), 2027–2032
 Table 43. Latin America On-body Injectors Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America On-body Injectors Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa On-body Injectors Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa On-body Injectors Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa On-body Injectors Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa On-body Injectors Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa On-body Injectors Revenue by Country (US$ Million), 2027–2032
 Table 50. Global On-body Injectors Sales (K Units) by Type (2021–2026)
 Table 51. Global On-body Injectors Sales (K Units) by Type (2027–2032)
 Table 52. Global On-body Injectors Sales Market Share by Type (2021–2026)
 Table 53. Global On-body Injectors Sales Market Share by Type (2027–2032)
 Table 54. Global On-body Injectors Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global On-body Injectors Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global On-body Injectors Revenue Market Share by Type (2021–2026)
 Table 57. Global On-body Injectors Revenue Market Share by Type (2027–2032)
 Table 58. Global On-body Injectors Price (US$/Unit) by Type (2021–2026)
 Table 59. Global On-body Injectors Price (US$/Unit) by Type (2027–2032)
 Table 60. Global On-body Injectors Sales (K Units) by Application (2021–2026)
 Table 61. Global On-body Injectors Sales (K Units) by Application (2027–2032)
 Table 62. Global On-body Injectors Sales Market Share by Application (2021–2026)
 Table 63. Global On-body Injectors Sales Market Share by Application (2027–2032)
 Table 64. Global On-body Injectors Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global On-body Injectors Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global On-body Injectors Revenue Market Share by Application (2021–2026)
 Table 67. Global On-body Injectors Revenue Market Share by Application (2027–2032)
 Table 68. Global On-body Injectors Price (US$/Unit) by Application (2021–2026)
 Table 69. Global On-body Injectors Price (US$/Unit) by Application (2027–2032)
 Table 70. West Pharmaceutical Services Company Information
 Table 71. West Pharmaceutical Services Description and Business Overview
 Table 72. West Pharmaceutical Services On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. West Pharmaceutical Services On-body Injectors Product
 Table 74. West Pharmaceutical Services Recent Developments/Updates
 Table 75. Insulet Company Information
 Table 76. Insulet Description and Business Overview
 Table 77. Insulet On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Insulet On-body Injectors Product
 Table 79. Insulet Recent Developments/Updates
 Table 80. Gerresheimer Company Information
 Table 81. Gerresheimer Description and Business Overview
 Table 82. Gerresheimer On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Gerresheimer On-body Injectors Product
 Table 84. Gerresheimer Recent Developments/Updates
 Table 85. United Therapeutics Company Information
 Table 86. United Therapeutics Description and Business Overview
 Table 87. United Therapeutics On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. United Therapeutics On-body Injectors Product
 Table 89. United Therapeutics Recent Developments/Updates
 Table 90. CC Bio Company Information
 Table 91. CC Bio Description and Business Overview
 Table 92. CC Bio On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. CC Bio On-body Injectors Product
 Table 94. CC Bio Recent Developments/Updates
 Table 95. BD Company Information
 Table 96. BD Description and Business Overview
 Table 97. BD On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. BD On-body Injectors Product
 Table 99. BD Recent Developments/Updates
 Table 100. Ypsomed Company Information
 Table 101. Ypsomed Description and Business Overview
 Table 102. Ypsomed On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Ypsomed On-body Injectors Product
 Table 104. Ypsomed Recent Developments/Updates
 Table 105. Enable Injections Company Information
 Table 106. Enable Injections Description and Business Overview
 Table 107. Enable Injections On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Enable Injections On-body Injectors Product
 Table 109. Enable Injections Recent Developments/Updates
 Table 110. Nemera Company Information
 Table 111. Nemera Description and Business Overview
 Table 112. Nemera On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Nemera On-body Injectors Product
 Table 114. Nemera Recent Developments/Updates
 Table 115. Stevanato Group Company Information
 Table 116. Stevanato Group Description and Business Overview
 Table 117. Stevanato Group On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Stevanato Group On-body Injectors Product
 Table 119. Stevanato Group Recent Developments/Updates
 Table 120. Sonceboz Company Information
 Table 121. Sonceboz Description and Business Overview
 Table 122. Sonceboz On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Sonceboz On-body Injectors Product
 Table 124. Sonceboz Recent Developments/Updates
 Table 125. Lohmann Therapie-Systeme Company Information
 Table 126. Lohmann Therapie-Systeme Description and Business Overview
 Table 127. Lohmann Therapie-Systeme On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Lohmann Therapie-Systeme On-body Injectors Product
 Table 129. Lohmann Therapie-Systeme Recent Developments/Updates
 Table 130. Elcam Drug Delivery Devices (E3D) Company Information
 Table 131. Elcam Drug Delivery Devices (E3D) Description and Business Overview
 Table 132. Elcam Drug Delivery Devices (E3D) On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Elcam Drug Delivery Devices (E3D) On-body Injectors Product
 Table 134. Elcam Drug Delivery Devices (E3D) Recent Developments/Updates
 Table 135. MicroMED Company Information
 Table 136. MicroMED Description and Business Overview
 Table 137. MicroMED On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 138. MicroMED On-body Injectors Product
 Table 139. MicroMED Recent Developments/Updates
 Table 140. Altek Medical Company Information
 Table 141. Altek Medical Description and Business Overview
 Table 142. Altek Medical On-body Injectors Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 143. Altek Medical On-body Injectors Product
 Table 144. Altek Medical Recent Developments/Updates
 Table 145. Key Raw Materials Lists
 Table 146. Raw Materials Key Suppliers Lists
 Table 147. On-body Injectors Distributors List
 Table 148. On-body Injectors Customers List
 Table 149. On-body Injectors Market Trends
 Table 150. On-body Injectors Market Drivers
 Table 151. On-body Injectors Market Challenges
 Table 152. On-body Injectors Market Restraints
 Table 153. Research Programs/Design for This Report
 Table 154. Key Data Information from Secondary Sources
 Table 155. Key Data Information from Primary Sources
 Table 156. Authors List of This Report


List of Figures
 Figure 1. Product Picture of On-body Injectors
 Figure 2. Global On-body Injectors Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global On-body Injectors Market Share by Type: 2025 & 2032
 Figure 4. Electronic Injectors Product Picture
 Figure 5. Mechanical Injectors Product Picture
 Figure 6. Global On-body Injectors Market Value by Application (US$ Million), 2021–2032
 Figure 7. Global On-body Injectors Market Share by Application: 2025 & 2032
 Figure 8. Immuno-oncology
 Figure 9. Cardiovascular Diseases
 Figure 10. Neurological Diseases
 Figure 11. Others
 Figure 12. Global On-body Injectors Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global On-body Injectors Market Size (US$ Million), 2021–2032
 Figure 14. Global On-body Injectors Sales (K Units), 2021–2032
 Figure 15. Global On-body Injectors Average Price (US$/Unit), 2021–2032
 Figure 16. On-body Injectors Report Years Considered
 Figure 17. On-body Injectors Sales Share by Manufacturers in 2025
 Figure 18. Global On-body Injectors Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global On-body Injectors Players: Market Share by Revenue in On-body Injectors in 2025
 Figure 20. On-body Injectors Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global On-body Injectors Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America On-body Injectors Sales Market Share by Country (2021–2032)
 Figure 23. North America On-body Injectors Revenue Market Share by Country (2021–2032)
 Figure 24. United States On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe On-body Injectors Sales Market Share by Country (2021–2032)
 Figure 27. Europe On-body Injectors Revenue Market Share by Country (2021–2032)
 Figure 28. Germany On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific On-body Injectors Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific On-body Injectors Revenue Market Share by Region (2021–2032)
 Figure 35. China On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America On-body Injectors Sales Market Share by Country (2021–2032)
 Figure 43. Latin America On-body Injectors Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Middle East and Africa On-body Injectors Sales Market Share by Country (2021–2032)
 Figure 48. Middle East and Africa On-body Injectors Revenue Market Share by Country (2021–2032)
 Figure 49. Turkey On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Saudi Arabia On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. UAE On-body Injectors Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. Global Sales Market Share of On-body Injectors by Type (2021–2032)
 Figure 53. Global Revenue Market Share of On-body Injectors by Type (2021–2032)
 Figure 54. Global On-body Injectors Price (US$/Unit) by Type (2021–2032)
 Figure 55. Global Sales Market Share of On-body Injectors by Application (2021–2032)
 Figure 56. Global Revenue Market Share of On-body Injectors by Application (2021–2032)
 Figure 57. Global On-body Injectors Price (US$/Unit) by Application (2021–2032)
 Figure 58. On-body Injectors Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension